Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Abcam 2,3-Butanedione 2-Monoxime, Non-selective Myosin ATPase Inhibitor, Solid, 500 mg

Catalog No. 502707421
Encompass_Preferred
Change view
Click to view available options
Quantity:
500 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
50-270-7421 500 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 50-270-7421 Supplier Abcam Supplier No. AB120616500MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Non-selective myosin ATPase inhibitor that is blood-brain barrier permeable and inhibits muscle contraction.

  • Molecular weight: 101.1 g/mol
  • Inhibitor type: Non-selective myosin ATPase inhibitor (Ki = 5 mM at myosin II)
  • Secondary inhibition: Potent Kv2.1 (DRK1) and L-Type Ca²± channel inhibitor (Ki and IC50 values are 10.7 nM and 5.8 mM, respectively)
  • Permeability: Blood-brain barrier permeable
  • Biological activity: Inhibits muscle contraction
  • Form: Solid
  • Composition: 100% (3E)-3-(hydroxyimino)butan-2-one

The product is subject to the following: Abcam Restricted Use Statement

Specifications

Target Molecule Myosin ATPase, Kv2.1, L-Type Ca2+ Channel
Substrate Properties Chemical Substrate
Content And Storage Store at ambient temperature.
Buffer 100% (3E)-3-(hydroxyimino)butan-2-one
Form Solid
Shipping Condition Ambient
Formulation 100% (3E)-3-(hydroxyimino)butan-2-one
Quantity 500 mg
For Use With (Application) Myosin ATPase inhibition, Ion channel inhibition, Muscle contraction inhibition
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.